Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
A study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis
CzechiaA study to evaluate the safety and effectiveness of resomelagon in patients with polymyalgia rheumatica who are in remission using glucocorticoids
DenmarkStudy to evaluate the effect of upadacitinib on the frequency of eye inflammation in patients with axial spondyloarthritis.
BulgariaA study to evaluate the effect of obinutuzumab on removing specific immune cells in the tissues of patients with Sjögren's syndrome.
The NetherlandsComparing the timing of etoposide and dexamethasone treatment for patients with severe sporadic hemophagocytic lymphohistiocytosis in intensive care.
FranceA study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis
AustriaA Study of Lebrikizumab for Adults and Adolescents with Moderate to Severe Atopic Dermatitis to Evaluate Effects on Eczema and Skin Barrier Function
SwedenA study testing teprotumumab compared to placebo in adult patients with moderate-to-severe active thyroid eye disease
FranceTesting acetylsalicylic acid and ketorolac to reduce complications after cancer surgery in patients with high inflammation levels
ItalyStudy of Fecal Microbiota Transplantation Compared to Sham Treatment for Patients with Primary Sclerosing Cholangitis
FranceA study to test if atorvastatin can prevent eye disease in patients newly diagnosed with Graves' disease
SwedenA study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease
DenmarkThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
